Home World News FDA Approves Treosulfan with Fludarabine As a Preparative Regimen for alloHSCT in...

FDA Approves Treosulfan with Fludarabine As a Preparative Regimen for alloHSCT in Adult and Paediatric Patients with AML or MDS

March 13, 2025

949

Evidence for efficacy is based on the results from the MC-FludT.14/L Trial II